Varex Imaging Corporation
General ticker "VREX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $463.1M (TTM average)
Varex Imaging Corporation follows the US Stock Market performance with the rate: 25.5%.
Estimated limits based on current volatility of 0.3%: low 18.47$, high 18.56$
Factors to consider:
- Total employees count: 2400 (+4.3%) as of 2025
- US accounted for 31.8% of revenue in the fiscal year ended 2024-09-27
- Top business risk factors: Trade tariffs, Margin erosion, Technology failures, Regulatory and compliance, Product liability
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-10-03 to 2027-10-03
- 2025-10-03 to 2026-10-03 estimated range: [9.65$, 16.88$]
- 2026-10-03 to 2027-10-03 estimated range: [11.21$, 19.02$]
Financial Metrics affecting the VREX estimates:
- Positive: with PPE of 13.8 at the end of fiscal year the price was very low
- Positive: -4.23 < Operating profit margin, % of -3.19
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 2.05 > -0.64
- Positive: 6.77 < Operating cash flow per share per price, % of 8.32
- Negative: Interest expense per share per price, % of 7.08 > 3.34
Short-term VREX quotes
Long-term VREX plot with estimates
Financial data
| YTD | 2023-09-29 | 2024-09-27 | 2025-10-03 |
|---|---|---|---|
| Operating Revenue | $893.40MM | $811.00MM | $844.60MM |
| Operating Expenses | $816.30MM | $778.90MM | $872.40MM |
| Operating Income | $77.10MM | $32.10MM | $-27.80MM |
| Non-Operating Income | $-45.80MM | $-27.10MM | $-31.40MM |
| Interest Expense | $29.30MM | $30.20MM | $35.50MM |
| R&D Expense | $84.80MM | $87.00MM | $91.10MM |
| Income(Loss) | $31.30MM | $5.00MM | $-59.20MM |
| Taxes | $-16.60MM | $53.30MM | $10.70MM |
| Net Income(Loss)* | $48.70MM | $-47.70MM | $-70.30MM |
| Stockholders Equity | $567.70MM | $529.10MM | $472.60MM |
| Inventory | $277.50MM | $264.80MM | $299.40MM |
| Assets | $1,249.60MM | $1,213.60MM | $1,107.40MM |
| Operating Cash Flow | $108.40MM | $47.30MM | $41.70MM |
| Capital expenditure | $20.70MM | $26.90MM | $22.90MM |
| Investing Cash Flow | $-44.90MM | $-27.50MM | $10.30MM |
| Financing Cash Flow | $-0.20MM | $-3.30MM | $-75.90MM |
| Earnings Per Share** | $1.21 | $-1.17 | $-1.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.